What is INFUSYSTEM HOLDINGS INC share price today?

INFUSYSTEM HOLDINGS INC (INFU) share price today is {{live_price}}.

Can Indians buy INFUSYSTEM HOLDINGS INC shares?

Yes, Indians can invest in the INFUSYSTEM HOLDINGS INC (INFU) from India. With INDmoney, you can buy INFUSYSTEM HOLDINGS INC at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy INFUSYSTEM HOLDINGS INC at zero transaction cost.

How can I buy INFUSYSTEM HOLDINGS INC shares from India?

It is very easy to buy INFUSYSTEM HOLDINGS INC from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of INFUSYSTEM HOLDINGS INC be purchased?

Yes, you can buy fractional shares of INFUSYSTEM HOLDINGS INC with INDmoney app.

What are the documents required to start investing in INFUSYSTEM HOLDINGS INC stocks?

To start investing in INFUSYSTEM HOLDINGS INC, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of INFUSYSTEM HOLDINGS INC

Today’s highest price of INFUSYSTEM HOLDINGS INC (INFU) is {{1_rba_end}}. Today’s lowest price of INFUSYSTEM HOLDINGS INC (INFU) is {{1_rba_st}}.

What is today's market capitalisation of INFUSYSTEM HOLDINGS INC

Today's market capitalisation of INFUSYSTEM HOLDINGS INC INFU is 186.3M

What is the 52 Week High and Low Range of INFUSYSTEM HOLDINGS INC

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage INFUSYSTEM HOLDINGS INC is down from its 52 Week High?

INFUSYSTEM HOLDINGS INC (INFU) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage INFUSYSTEM HOLDINGS INC is up from its 52 Week low?

INFUSYSTEM HOLDINGS INC (INFU) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of INFUSYSTEM HOLDINGS INC?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of INFUSYSTEM HOLDINGS INC

Mr. Richard A. DiIorio is the current Chief Executive Officer (CEO) of INFUSYSTEM HOLDINGS INC.

Home

US Stocks

INFUSYSTEM HOLDINGS INC

INFUSYSTEM HOLDINGS INC (INFU)

$8.8

-0.1

(-1.12%)▲

Live

Insights on INFUSYSTEM HOLDINGS INC

Increasing Revenue
Revenue is up for the last 6 quarters, 26.51M → 30.37M (in $), with an average increase of 2.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 443.0K → -324.0K (in $), with an average decrease of 239.3% per quarter
Vs ISRG
In the last 1 year, Intuitive Surgical Inc has given 33.9% return, outperforming this stock by 41.3%
Vs WST
In the last 3 years, West Pharmaceutical Services, Inc. has given 58.7% return, outperforming this stock by 82.0%

Performance

$8.80
$9.17
$8.80
0.0%
Downside
Day's Volatility :4.03%
Upside
4.03%
$6.10
$10.88
$8.80
30.68%
Downside
52 Weeks Volatility :43.93%
Upside
19.12%

Returns

Period	INFUSYSTEM HOLDINGS INC	Sector (Health Care)	Index (Russel 2000)
3 Months	-5.22%	0.3%	-6.7%
6 Months	3.73%	-8.3%	-6.2%
1 Year	-7.96%	-4.8%	-6.3%
3 Years	-23.93%	23.8%	26.9%

Highlights

Market Capitalization	186.3M
Book Value	$2.31
Dividend Share	0.0
Dividend Yield	0.0%
Earnings Per Share (EPS)	0.0
PE Ratio	0.0
PEG Ratio	0.0
Wall Street Target Price	15.17

Profit Margin	0.06%
Operating Margin TTM	1.83%

Return On Assets TTM	1.29%
Return On Equity TTM	0.13%

Revenue TTM	113.4M
Revenue Per Share TTM	5.47
Quarterly Revenue Growth YOY	13.3%
Gross Profit TTM	62.5M
EBITDA	15.1M
Diluted Eps TTM	0.0
Quarterly Earnings Growth YOY	-0.5

EPS Estimate Current Year	0.06
EPS Estimate Next Year	0.22
EPS Estimate Current Quarter	0.02
EPS Estimate Next Quarter	0.03

Analyst Recommendation

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for INFUSYSTEM HOLDINGS INC(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 72.39%

Current $8.80

Target $15.17

Company Financials

	FY17	Y/Y Change
Revenue	71.1M	↑ 0.82%
Net Income	-20.7M	↑ 9227.48%
Net Profit Margin	-29.13%	↓ 28.82%

	FY18	Y/Y Change
Revenue	67.1M	↓ 5.54%
Net Income	-1.1M	↓ 94.71%
Net Profit Margin	-1.63%	↑ 27.5%

	FY19	Y/Y Change
Revenue	81.1M	↑ 20.82%
Net Income	1.4M	↓ 224.29%
Net Profit Margin	1.68%	↑ 3.31%

	FY20	Y/Y Change
Revenue	97.4M	↑ 20.06%
Net Income	17.3M	↑ 1173.48%
Net Profit Margin	17.8%	↑ 16.12%

	FY21	Y/Y Change
Revenue	102.4M	↑ 5.13%
Net Income	1.4M	↓ 91.81%
Net Profit Margin	1.39%	↓ 16.41%

	FY22	Y/Y Change
Revenue	109.9M	↑ 7.36%
Net Income	18.0K	↓ 98.73%
Net Profit Margin	0.02%	↓ 1.37%

	Q4 FY21	Q/Q Change
Revenue	26.5M	↓ 0.18%
Net Income	387.0K	↓ 186.38%
Net Profit Margin	1.46%	↑ 3.15%

	Q1 FY22	Q/Q Change
Revenue	26.8M	↑ 0.92%
Net Income	-368.0K	↓ 195.09%
Net Profit Margin	-1.38%	↓ 2.84%

	Q2 FY22	Q/Q Change
Revenue	27.0M	↑ 1.04%
Net Income	-164.0K	↓ 55.43%
Net Profit Margin	-0.61%	↑ 0.77%

	Q3 FY22	Q/Q Change
Revenue	27.3M	↑ 0.88%
Net Income	443.0K	↓ 370.12%
Net Profit Margin	1.62%	↑ 2.23%

	Q4 FY22	Q/Q Change
Revenue	28.8M	↑ 5.69%
Net Income	107.0K	↓ 75.85%
Net Profit Margin	0.37%	↓ 1.25%

	Q1 FY23	Q/Q Change
Revenue	30.4M	↑ 5.34%
Net Income	-324.0K	↓ 402.8%
Net Profit Margin	-1.07%	↓ 1.44%

	FY17	Y/Y Change
Total Assets	68.9M	↓ 28.51%
Total Liabilities	37.9M	↓ 16.92%

	FY18	Y/Y Change
Total Assets	64.1M	↓ 6.98%
Total Liabilities	43.6M	↑ 15.04%

	FY19	Y/Y Change
Total Assets	79.2M	↑ 23.65%
Total Liabilities	56.9M	↑ 30.39%

	FY20	Y/Y Change
Total Assets	45.2M	↓ 42.89%
Total Liabilities	56.2M	↓ 1.14%

	FY21	Y/Y Change
Total Assets	97.6M	↑ 115.69%
Total Liabilities	49.3M	↓ 12.31%

	FY22	Y/Y Change
Total Assets	99.4M	↑ 1.85%
Total Liabilities	51.4M	↑ 4.2%

	Q4 FY21	Q/Q Change
Total Assets	97.6M	↑ 2.95%
Total Liabilities	49.3M	↑ 2.03%

	Q1 FY22	Q/Q Change
Total Assets	98.2M	↑ 0.67%
Total Liabilities	52.2M	↑ 5.82%

	Q2 FY22	Q/Q Change
Total Assets	98.8M	↑ 0.59%
Total Liabilities	52.3M	↑ 0.26%

	Q3 FY22	Q/Q Change
Total Assets	99.0M	↑ 0.17%
Total Liabilities	51.2M	↓ 2.19%

	Q4 FY22	Q/Q Change
Total Assets	99.4M	↑ 0.41%
Total Liabilities	51.4M	↑ 0.41%

	Q1 FY23	Q/Q Change
Total Assets	102.3M	↑ 2.89%
Total Liabilities	54.0M	↑ 5.09%

	FY17	Y/Y Change
Operating Cash Flow	7.6M	↓ 4.12%
Investing Cash Flow	1.1M	↓ 119.7%
Financing Cash Flow	-8.6M	↓ 57200.0%

	FY18	Y/Y Change
Operating Cash Flow	11.4M	↑ 50.22%
Investing Cash Flow	-5.0M	↓ 573.31%
Financing Cash Flow	-5.6M	↓ 35.11%

	FY19	Y/Y Change
Operating Cash Flow	13.9M	↑ 21.81%
Investing Cash Flow	-19.6M	↑ 294.12%
Financing Cash Flow	4.1M	↓ 173.71%

	FY20	Y/Y Change
Operating Cash Flow	20.3M	↑ 46.16%
Investing Cash Flow	-12.2M	↓ 38.08%
Financing Cash Flow	-1.1M	↓ 127.26%

	FY21	Y/Y Change
Operating Cash Flow	18.3M	↓ 9.68%
Investing Cash Flow	-21.3M	↑ 75.26%
Financing Cash Flow	-6.5M	↑ 478.6%

	Q4 FY21	Q/Q Change
Operating Cash Flow	3.7M	↓ 35.92%
Investing Cash Flow	-5.6M	↑ 27.19%
Financing Cash Flow	1.9M	↓ 241.8%

	Q1 FY22	Q/Q Change
Operating Cash Flow	4.1M	↑ 9.89%
Investing Cash Flow	-2.1M	↓ 61.92%
Financing Cash Flow	-1.7M	↓ 188.59%

	Q2 FY22	Q/Q Change
Operating Cash Flow	5.4M	↑ 32.83%
Investing Cash Flow	-2.8M	↑ 29.77%
Financing Cash Flow	-2.7M	↑ 59.09%

	Q3 FY22	Q/Q Change
Operating Cash Flow	3.5M	↓ 36.2%
Investing Cash Flow	-3.5M	↑ 25.93%
Financing Cash Flow	98.0K	↓ 103.59%

Technicals Summary

Sell

Neutral

Buy

INFUSYSTEM HOLDINGS INC is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
INFUSYSTEM HOLDINGS INC	0.79%	3.73%	-7.96%	-23.93%	182.54%
Intuitive Surgical, Inc.	1.28%	13.5%	34.82%	60.24%	100.3%
ResMed Inc.	-8.1%	-6.41%	5.89%	33.71%	110.04%
Becton, Dickinson and Company	-9.12%	-3.3%	-5.74%	-1.52%	7.87%
West Pharmaceutical Services Inc	-6.18%	46.38%	10.67%	61.92%	264.96%
Alcon AG	9.79%	14.75%	5.78%	24.18%	36.2%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
INFUSYSTEM HOLDINGS INC	0.0	0.0	0.0	0.06	0.0	0.01	0.0	2.31
Intuitive Surgical, Inc.	83.4	83.4	3.27	5.47	0.11	0.07	0.0	32.01
ResMed Inc.	36.76	36.76	1.74	6.52	0.24	0.12	0.01	26.77
Becton, Dickinson and Company	44.32	44.32	2.31	12.2	0.07	0.03	0.02	90.44
West Pharmaceutical Services Inc	47.18	47.18	4.06	7.69	0.22	0.13	0.0	37.42
Alcon AG	114.57	114.57	NA	2.64	0.02	0.02	0.0	40.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
INFUSYSTEM HOLDINGS INC	Buy	$186.3M	182.54%	0.0	0.06%
Intuitive Surgical, Inc.	Buy	$107.5B	100.3%	83.4	20.4%
ResMed Inc.	Buy	$31.7B	110.04%	36.76	21.49%
Becton, Dickinson and Company	Buy	$68.5B	7.87%	44.32	8.6%
West Pharmaceutical Services Inc	Buy	$25.5B	264.96%	47.18	19.15%
Alcon AG	Buy	$38.9B	36.2%	114.57	3.84%

Organization	INFUSYSTEM HOLDINGS INC
Employees	420
CEO	Mr. Richard A. DiIorio
Industry	Health Technology

INFUSYSTEM HOLDINGS INC (INFU)

Insights on INFUSYSTEM HOLDINGS INC

Increasing Revenue

Decreasing Net Profit

Vs ISRG

Vs WST